Does EVEROLIMUS Cause Epistaxis? 598 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 598 reports of Epistaxis have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 1.5% of all adverse event reports for EVEROLIMUS.
598
Reports of Epistaxis with EVEROLIMUS
1.5%
of all EVEROLIMUS reports
62
Deaths
212
Hospitalizations
How Dangerous Is Epistaxis From EVEROLIMUS?
Of the 598 reports, 62 (10.4%) resulted in death, 212 (35.5%) required hospitalization, and 21 (3.5%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for EVEROLIMUS.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which EVEROLIMUS Alternatives Have Lower Epistaxis Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE